In contrast, the PERKi could significantly inhibit the growth of both BRAFi-resistant melanoma cell lines with impaired PTEN, while exhibiting little effect on the growth of both their parental melanoma cell lines (Fig. 2c, d). Here, PTEN is linked to melanoma.